How to use this Idexx Laboratories investment calculator
This page shows how Idexx Laboratories stock has performed historically and links to year-specific investment calculators. Use the calculators below to see exactly what a $1,000 investment made in any year would be worth today. Each calculator shows total return, annualised growth rate (CAGR), and an interactive price chart.
Idexx Laboratories Investment Calculators
Select a year to see stock price return from that year to today:
stock price return 2024 ▲ 18.4%
stock price return 2023 ▲ 59.8%
stock price return 2022 ▲ 2.8%
stock price return 2021 ▲ 31.9%
stock price return 2020 ▲ 144.8%
stock price return 2019 ▲ 255.5%
stock price return 2018 ▲ 311.1%
stock price return 2017 ▲ 451.6%
stock price return 2016 ▲ 847.5%
stock price return
What Drives Idexx Laboratories Stock Returns?
When most people think about healthcare stocks, they picture hospitals or drug companies. Idexx Laboratories operates in a different corner entirely - they're the dominant player in veterinary diagnostics and testing. Founded in 1983 in Maine, the company makes the blood analyzers, chemistry panels, and rapid tests that veterinarians use to diagnose everything from kidney disease in cats to heartworm in dogs. They also handle water quality testing and livestock diagnostics, but the companion animal business drives the story. The numbers tell you everything about their competitive position. Under former CEO Jon Ayers' 20-year run, annual revenue jumped from $380 million to $3 billion while shares climbed 100-fold. That kind of sustained growth doesn't happen by accident - it happens when you build deep moats around your business. Veterinary practices become sticky customers once they install Idexx equipment and train staff on the systems. What makes this stock interesting to investors is the structural tailwind behind it. Pet ownership keeps growing, and pet parents increasingly treat their animals like family members, spending more on healthcare. The recurring revenue model from consumables and services creates predictable cash flows. Plus, with operations in over 175 countries, there's still plenty of runway for international expansion as veterinary care standards rise globally.
Idexx Laboratories Historical Performance
Idexx Laboratories has been a classic growth stock with pronounced boom-bust cycles that made entry timing critical for investor returns. The veterinary diagnostics company demonstrated explosive growth potential during favorable periods, but also experienced sharp corrections that could wipe out years of gains within months. This created a stark divide between investors who caught the momentum phases versus those who bought during peak valuations. The stock showed distinct growth phases punctuated by significant pullbacks, rather than steady compounding returns. During bull runs, IDXX could deliver exceptional performance as investors bid up its premium valuation, but these periods were followed by brutal corrections when sentiment shifted or growth expectations weren't met. The company's exposure to discretionary veterinary spending and competitive pressures in diagnostics created additional volatility beyond typical growth stock fluctuations. For IDXX, when you invested mattered far more than how long you held. The year-by-year calculators reveal the dramatic difference between buying during growth phases versus correction periods, highlighting why this stock required careful timing rather than a buy-and-hold approach.
Idexx Laboratories Stock Splits
Idexx Laboratories has not executed any stock splits during our tracked period from 2016 to present. The company has maintained its existing share structure without subdividing shares to reduce the per-share price or increase share count. For investors tracking IDXX, this means the share count and price history remain unadjusted for split activity during this timeframe. Our calculators and historical data presentations automatically account for any stock splits when they occur, ensuring accurate comparisons across different time periods and consistent per-share metrics for analysis.
No stock splits recorded in our data period.
Idexx Laboratories Dividends & Total Returns
Idexx Laboratories has not paid any dividends during our tracked period from 2016 to present, with our records showing 0 dividend payments. The company has maintained a non-dividend policy throughout this timeframe, directing capital toward business operations and growth initiatives rather than cash distributions to shareholders. For investors analyzing IDXX returns, the absence of dividend payments means that price appreciation represents the sole component of total returns. Our return calculators reflect this by showing price returns, which equal total returns for this stock since no dividend income is generated. This dividend structure is common among growth-oriented companies in the healthcare technology sector that prioritize reinvestment over shareholder distributions.